ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,466,953 | -19.6% | 536,294 | +13.0% | 0.00% | – |
| Q2 2023 | $3,066,762 | -42.8% | 474,731 | -33.3% | 0.00% | -100.0% |
| Q1 2023 | $5,363,000 | +89149.5% | 711,286 | +19.9% | 0.00% | 0.0% |
| Q4 2022 | $6,009 | -99.9% | 593,184 | +18.6% | 0.00% | 0.0% |
| Q3 2022 | $4,947,000 | +13.3% | 500,130 | +22.0% | 0.00% | 0.0% |
| Q2 2022 | $4,368,000 | +196.9% | 410,104 | +171.8% | 0.00% | – |
| Q1 2022 | $1,471,000 | +25.4% | 150,882 | +83.9% | 0.00% | – |
| Q4 2021 | $1,173,000 | – | 82,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |